P570: VENETOCLAX PLUS HYPOMETHYLATING AGENTS VERSUS INTENSIVE CHEMOTHERAPY FOR HEMATOLOGICAL RELAPSE OF MYELOID MALIGNANCIES AFTER ALLO-HSCT

Detalles Bibliográficos
Autores principales: Chen, Zhangjie, Zhen, Sisi, Chen, Xin, Feng, Sizhou
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Lippincott Williams & Wilkins 2023
Materias:
Posters
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10428869/
http://dx.doi.org/10.1097/01.HS9.0000969184.80765.e2
_version_ 1785090573505396736
author Chen, Zhangjie
Zhen, Sisi
Chen, Xin
Feng, Sizhou
author_facet Chen, Zhangjie
Zhen, Sisi
Chen, Xin
Feng, Sizhou
author_sort Chen, Zhangjie
collection PubMed
description
format Online
Article
Text
id pubmed-10428869
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Lippincott Williams & Wilkins
record_format MEDLINE/PubMed
spelling pubmed-104288692023-08-17 P570: VENETOCLAX PLUS HYPOMETHYLATING AGENTS VERSUS INTENSIVE CHEMOTHERAPY FOR HEMATOLOGICAL RELAPSE OF MYELOID MALIGNANCIES AFTER ALLO-HSCT Chen, Zhangjie Zhen, Sisi Chen, Xin Feng, Sizhou Hemasphere Posters Lippincott Williams & Wilkins 2023-08-08 /pmc/articles/PMC10428869/ http://dx.doi.org/10.1097/01.HS9.0000969184.80765.e2 Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access Abstract Book distributed under the Attribution-NonCommercial-NoDerivs (CC BY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) which allows third parties to download the articles and share them with others as long as they credit the author and the Abstract Book, but they cannot change the content in any way or use them commercially.
spellingShingle Posters
Chen, Zhangjie
Zhen, Sisi
Chen, Xin
Feng, Sizhou
P570: VENETOCLAX PLUS HYPOMETHYLATING AGENTS VERSUS INTENSIVE CHEMOTHERAPY FOR HEMATOLOGICAL RELAPSE OF MYELOID MALIGNANCIES AFTER ALLO-HSCT
title P570: VENETOCLAX PLUS HYPOMETHYLATING AGENTS VERSUS INTENSIVE CHEMOTHERAPY FOR HEMATOLOGICAL RELAPSE OF MYELOID MALIGNANCIES AFTER ALLO-HSCT
title_full P570: VENETOCLAX PLUS HYPOMETHYLATING AGENTS VERSUS INTENSIVE CHEMOTHERAPY FOR HEMATOLOGICAL RELAPSE OF MYELOID MALIGNANCIES AFTER ALLO-HSCT
title_fullStr P570: VENETOCLAX PLUS HYPOMETHYLATING AGENTS VERSUS INTENSIVE CHEMOTHERAPY FOR HEMATOLOGICAL RELAPSE OF MYELOID MALIGNANCIES AFTER ALLO-HSCT
title_full_unstemmed P570: VENETOCLAX PLUS HYPOMETHYLATING AGENTS VERSUS INTENSIVE CHEMOTHERAPY FOR HEMATOLOGICAL RELAPSE OF MYELOID MALIGNANCIES AFTER ALLO-HSCT
title_short P570: VENETOCLAX PLUS HYPOMETHYLATING AGENTS VERSUS INTENSIVE CHEMOTHERAPY FOR HEMATOLOGICAL RELAPSE OF MYELOID MALIGNANCIES AFTER ALLO-HSCT
title_sort p570: venetoclax plus hypomethylating agents versus intensive chemotherapy for hematological relapse of myeloid malignancies after allo-hsct
topic Posters
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10428869/
http://dx.doi.org/10.1097/01.HS9.0000969184.80765.e2
work_keys_str_mv AT chenzhangjie p570venetoclaxplushypomethylatingagentsversusintensivechemotherapyforhematologicalrelapseofmyeloidmalignanciesafterallohsct
AT zhensisi p570venetoclaxplushypomethylatingagentsversusintensivechemotherapyforhematologicalrelapseofmyeloidmalignanciesafterallohsct
AT chenxin p570venetoclaxplushypomethylatingagentsversusintensivechemotherapyforhematologicalrelapseofmyeloidmalignanciesafterallohsct
AT fengsizhou p570venetoclaxplushypomethylatingagentsversusintensivechemotherapyforhematologicalrelapseofmyeloidmalignanciesafterallohsct

Ejemplares similares